XNAS · Laboratory Analytical Instruments · S&P 500
$11.03
+$0.32 (+3.04%) today
Open $10.71 High $11.03 Low $10.70 Vol 5K Avg $10.83
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| SINT | SiNtx Technologies, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BAX | Baxter International Inc. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| BSX | Boston Scientific Corp. | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| TNON | Tenon Medical, Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| SSII | SS Innovations International Inc. Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| IART | Integra LifeSciences Holdings | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NVNO | enVVeno Medical Corporation Common Stock | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| NEGG | Newegg Commerce, Inc. Common Shares | XNAS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| MMM | 3M Company | XNYS | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| XTNT | Xtant Medical Holdings, Inc. | XASE | USD | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
52-week price range
Price is 27.2% above its 52-week low and 94.0% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.